By Tim Ryan
We’ve reported many accomplishments from ivWatch in 2024, and their accolades keep coming in. Here is the latest: ivWatch has also been recognized as one of Modern Healthcare’s 2024 Best in Business awardees, further underscoring its impact on the industry. Learn more about this achievement at ivWatch Modern Healthcare Recognition. The healthcare industry thrives on innovation, and in 2024, ivWatch is proudly leading the charge. Recently named one of the Best in Business awardees for its exceptional contributions to the Medical Technology category, ivWatch continues to revolutionize patient safety and redefine standards in IV therapy. This esteemed program celebrates organizations that drive efficiency, innovation, and excellence across healthcare, and ivWatch’s achievements underscore its critical role in enhancing the global healthcare ecosystem.
Setting a New Standard in IV Therapy
Founded on a mission to solve one of healthcare’s most persistent challenges, ivWatch has developed a groundbreaking FDA-cleared Class II medical device designed for continuous IV monitoring. Utilizing advanced optical technology, the device performs 18,000 checks per hour to detect changes in tissue properties around an IV site. This early detection capability prevents infiltration or extravasation—a common complication affecting 50% of peripheral IVs annually. By reducing risks of patient injuries and improving diagnostic accuracy, ivWatch is setting an unparalleled benchmark for IV safety worldwide.
Achievements That Make a Difference
The impact of ivWatch’s innovation is evident in its track record:
- 100% reduction in extravasation injuries in monitored trials.
- Over 300,000 patients monitored with 9 million hours of monitoring to date.
- A recent FDA clearance for monitoring iron sucrose infusions, addressing a high-risk area with lifelong tissue damage implications.
- An 83% surge in single-use sensor sales from 2023 to 2024.
- Expansion into 13 countries and a 430% increase in product evaluations over the past year.
These achievements highlight ivWatch’s rapid adoption in both domestic and international healthcare markets, underscoring its value in protecting patients and empowering clinicians.
A Proven Leader in Precision and Impact
What truly sets ivWatch apart is its precision and reliability. The device’s ability to perform continuous monitoring with unparalleled accuracy has gained the trust of top institutions, including three of the top 10 children’s hospitals in the United States. With an impressive portfolio of 69 patents, ivWatch is cementing its legacy as a global leader in IV safety.
As ivWatch’s technology reaches more patients worldwide, its mission remains steadfast: to make IV therapy safer and more reliable for everyone. This recognition as a Best in Business awardee is a testament to the company’s unwavering commitment to improving healthcare standards and outcomes.
Looking Ahead
ivWatch’s continued growth and innovation signal a transformative era in healthcare. With a proven track record, global expansion, and cutting-edge technology, ivWatch is not just setting a new standard—it is shaping the future of IV therapy and patient safety.
